Scott Plotkin

基本信息

浏览量：197

职业迁徙

个人简介

American Board Certifications
Neurology, American Board of Psychiatry and Neurology

研究兴趣

论文共 378 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Challenges in Assessing Response in Clinical Trials for Neurofibromatosis Type 1 Plexiform Neurofibromas

Eva Dombi, Andrea M Gross,Brigitte C Widemann, Brian D Weiss,Scott R Plotkin,Shivani Ahlawat

Journal of clinical oncology official journal of the American Society of Clinical Oncologyno. 15 (2025): 1843-1844

引用0浏览0WOS引用

Self-reported Access to Specialty Clinics and Receipt of Health Surveillance among U.S. Patients with Neurofibromatosis 1: A National Survey

Vanessa L. Merker,Yidan Ma,Lori B. Chibnik,Heather B. Radtke, Kate Kelts,Kaleb Yohay,Nicole J. Ullrich,Scott R. Plotkin,Justin T. Jordan

Orphanet Journal of Rare Diseasesno. 1 (2025): 1-9

引用0浏览0WOS引用

Brigatinib in NF2 -Related Schwannomatosis with Progressive Tumors

Scott R. Plotkin,Kaleb H. Yohay,Phioanh L. Nghiemphu,Christine T. Dinh,Dusica Babovic-Vuksanovic,Vanessa L. Merker,Annette Bakker,Geoffrey Fell,Lorenzo Trippa,Jaishri O. Blakeley

NEW ENGLAND JOURNAL OF MEDICINEno. 24 (2024): 2284-2294

引用0浏览0WOS引用

Phase 1b/2 Study of Orally Administered Pexidartinib in Combination with Radiation Therapy and Temozolomide in Patients with Newly Diagnosed Glioblastoma

NEURO-ONCOLOGY ADVANCESno. 1 (2024)

引用0浏览0WOS引用

Unlocking Brigatinib’s Potential: A Remarkable Case of Drug Repurposing in NF2-SWN

Annette Bakker, D. Wade Clapp, James Gusella, Jaishri Blakeley,Scott Plotkin, Marc Ferrer

Repurposed Drugs - Current State and Future Perspectives Working Title (2024)

引用0浏览0引用

Integrating Ataxia Evaluation into Tumor-Induced Hearing Loss Model to Comprehensively Study NF2-Related Schwannomatosis

Simeng Lu,Zhenzhen Yin,Jie Chen,Limeng Wu,Yao Sun,Xing Gao,Peigen Huang,Justin T. Jordan,Scott R. Plotkin,Lei Xu

CANCERS（2024）

引用0浏览0WOS引用

Platform Trial Design for Neurofibromatosis Type 1, NF2-related Schwannomatosis and Non-Nf2-related Schwannomatosis: A Potential Model for Rare Diseases

NEURO-ONCOLOGY PRACTICEno. 4 (2024): 395-403

引用2浏览0WOS引用

Advancing Neurofibromatosis and Schwannomatosis Clinical Trial Design: Consensus Recommendations from the Response Evaluation in Neurofibromatosis and Schwannomatosis (reins) International Collaboration

Vanessa L. Merker,Andrea M. Gross,Brigitte C. Widemann,Scott R. Plotkin

CLINICAL TRIALSno. 1 (2024): 3-5

引用0浏览0WOS引用

Gene-targeted Therapy for Neurofibromatosis and Schwannomatosis: the Path to Clinical Trials

Verena Staedtke,Kara Anstett,David Bedwell,Marco Giovannini,Kim Keeling,Robert Kesterson, YooRi Kim,Bruce Korf,Andre Leier, Miranda L. McManus,Herb Sarnoff,Jeremie Vitte,James A. Walker,Scott R. Plotkin,Deeann Wallis

CLINICAL TRIALSno. 1 (2024): 51-66

引用4浏览0WOS引用

Preclinical Evaluation of the Third-Generation, Bi-Steric Mtorc1-Selective Inhibitor RMC-6272 in NF2-deficient Models

Srirupa Bhattacharyya,Janet L. Oblinger,Roberta L. Beauchamp, Lili Kosa,Françis Robert,Scott R. Plotkin,Long‐Sheng Chang,Vijaya Ramesh

Neuro-Oncology Advancesno. 1 (2024)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

教授

论文共 378 篇作者统计合作学者相似作者